ArticleBMC microbiology2026
Multi-omics integration reveals the link between gut microbiota dysbiosis, host metabolic dysregulation, and aortic inflammation in abdominal aortic aneurysm.
Article in BMC microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
backgroundAn abdominal aortic aneurysm (AAA) is a localized expansion of the abdominal aorta, in which the vessel diameter exceeds 3 cm or is increased by more than 50% compared to the normal expected size. It has been increasingly recognized as a systemic disease involving complex interactions between vascular tissues and extra-aortic factors, particularly host metabolism and inflammation. The aim for the study was to integrate multi-omics approaches to systematically investigate the molecular mechanisms underlying AAA.
resultsSignificantly reduced α-diversity Pielou’s evenness was observed in AAA mice with downregulated Bacteroides acidifaciens, Bacteroides caecimuris, Bacteroides fragilis and upregulated Roseburia sp_1XD42_69, Chlamydia abortus, Eubacterium plexicaudatum, Eubacterium sp.14_2. Additionally, the metabolic profiles of cecal contents and serum were significantly altered in AAA mice compared to those in sham mice, with synchronous enrichment of the primary bile acid biosynthesis pathway in both compartments. Notably, 17 metabolites exhibited coordinated alterations and significant positive correlations. Transcriptomics revealed activated inflammatory pathways (leukocyte recruitment and NF-κB signaling) and increased immune infiltration in AAA aortas. Integrated analysis further revealed impaired gut microbial amino acid metabolism, accompanied by intestinal accumulation of L-leucine and L-arginine. The levels of primary and secondary bile acids showed a distinct compartmental imbalance. Weighted gene co-expression network modeling revealed a significant inverse correlation between serum bile acid levels and aortic gene modules enriched in inflammatory/chemokine signaling and cell adhesion pathways. Multi-omics integration using DIABLO further identified a coordinated signature across transcriptomic, microbiomic, and metabolomic layers, distinguishing AAA from sham mice and revealing candidate biomarker features associated with AAA.
conclusionsAAA mice exhibited dysbiosis of the gut microbiota and alterations in the metabolic profile. Disrupted gut microbiota was associated with dysregulation of amino acid metabolism, whereas imbalanced bile acid metabolism was correlated with aortic inflammatory responses.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.